We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+16.87%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$243B
AUM Growth
-$8.36B
Cap. Flow
-$4.19B
Cap. Flow %
-1.72%
Top 10 Hldgs %
24.56%
Holding
10,685
New
1,860
Increased
3,498
Reduced
3,278
Closed
1,970

Top Buys

Rank Stock Value
1
BA icon
Boeing
BA
+$923M
2
DIS icon
Walt Disney
DIS
+$710M
3
BAC icon
Bank of America
BAC
+$510M
4
AMZN icon
Amazon
AMZN
+$481M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$393M

Sector Composition

Rank Sector Weight
1 Miscellaneous 92.32%
2 Technology 1.44%
3 Communication Services 1.2%
4 Consumer Discretionary 1.2%
5 Financials 0.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SDLP
8626
DELISTED
SEADRILL PARTNERS LLC
SDLP
$10K ﹤0.01%
+1,215
New +$14.2K
GNCA
8627
DELISTED
Genocea Biosciences, Inc.
GNCA
$10K ﹤0.01%
+2,075
New +$10.3K
ASCMA
8628
CALL
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
$10K ﹤0.01%
13,600
SPHS
8629
PUT
DELISTED
Sophiris Bio, Inc.
SPHS
$10K ﹤0.01%
10,500
-14,800
-58% -$15.9K
CLIR icon
8630
ClearSign Technologies
CLIR
$30.8M
$9K ﹤0.01%
+1,056
New +$11.6K
PRSO icon
8631
Peraso
PRSO
$9.83M
$9K ﹤0.01%
+64
New +$9.21K
TOVX icon
8632
Theriva Biologics
TOVX
$11.6M
$8K ﹤0.01%
+49
New +$8.12K
XPL icon
8633
Solitario Resources
XPL
$76.9M
$8K ﹤0.01%
18,686
+6,558
+54% +$2.03K
SRTSW
8634
DELISTED
Sensus Healthcare, Inc. Warrant expiring on 06/08/2020
SRTSW
$8K ﹤0.01%
15,187
+1,323
+10% +$1.2K
AGIG
8635
Abundia Global Impact Group
AGIG
$42.8M
$7K ﹤0.01%
250
+114
+84% +$2.97K
NAK
8636
CALL
Northern Dynasty Minerals
NAK
$984M
$7K ﹤0.01%
11,800
-33,600
-74% -$26.2K
IRD
8637
CALL
Opus Genetics
IRD
$320M
$7K ﹤0.01%
294
-66
-18% -$2.19K
BVXVW
8638
DELISTED
BiondVax Pharmaceuticals Ltd.
BVXVW
$7K ﹤0.01%
20,962
-400
-2% -$224
AMRWW
8639
DELISTED
Alta Mesa Resources Inc Warrant
AMRWW
$7K ﹤0.01%
188,187
+59,338
+46% +$4.31K
PLX icon
8640
CALL
Protalix BioTherapeutics
PLX
$210M
$6K ﹤0.01%
1,400
-1,440
-51% -$6.49K
GMO
8641
DELISTED
General Moly, Inc.
GMO
$6K ﹤0.01%
26,805
+9,158
+52% +$2.25K
ONCS
8642
DELISTED
OncoSec Medical Incorporated
ONCS
$6K ﹤0.01%
+51
New +$6.97K
ARMP icon
8643
Armata Pharmaceuticals
ARMP
$202M
$5K ﹤0.01%
+1,286
New +$4.89K
FCEL icon
8644
PUT
FuelCell Energy
FCEL
$1.54B
$5K ﹤0.01%
58
-278
-83% -$48K
NRXPW
8645
DELISTED
NRX Pharmaceuticals Warrant
NRXPW
$5K ﹤0.01%
28,168
ONTXW
8646
DELISTED
Onconova Therapeutics, Inc. Warrants
ONTXW
$5K ﹤0.01%
+88,171
New +$11.2K
EPE
8647
PUT
DELISTED
EP Energy Corporation
EPE
$5K ﹤0.01%
+19,500
New +$12.9K
ADILW
8648
DELISTED
Adial Pharmaceuticals Warrant
ADILW
$4K ﹤0.01%
11,000
-7,069
-39% -$5.17K
BRPAR
8649
DELISTED
Big Rock Partners Acquisition Corp. Right
BRPAR
$4K ﹤0.01%
12,023
+500
+4% +$145
GPAQW
8650
DELISTED
Gordon Pointe Acquisition Corp. Warrant
GPAQW
$4K ﹤0.01%
+11,660
New +$4.71K

Similar funds

Jeff Yass's Q1 2019 Portfolio in Review

As of Q1 2019, Jeff Yass held 10,685 positions worth $243B, down 3.3% from $252B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Jeff Yass's Q1 2019 filing shows 1,860 new, 3,498 increased, 3,278 reduced and 1,970 closed positions. Its largest new stake was iShares China Large-Cap ETF: 4,340,587 shares worth $192M. The largest sale was Apple, an estimated $2.65B.

By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, down from 93% a quarter earlier, followed by Technology and Communication Services.

  • Jeff Yass's largest Q1 2019 buy was iShares China Large-Cap ETF: 4,340,587 shares worth $192M.
  • Jeff Yass added most to Boeing in Q1 2019, an estimated $923M increase.
  • Jeff Yass's biggest Q1 2019 reduction was Apple, cutting an estimated $2.65B.
  • Jeff Yass fully exited State Street SPDR S&P 500 ETF Trust in Q1 2019, selling an estimated $678M.
  • Jeff Yass's ten largest holdings make up 25% of its $243B portfolio in Q1 2019.
  • Jeff Yass opened 1,860 new positions and closed 1,970 in Q1 2019.
  • Jeff Yass's portfolio value fell 3.3% quarter-over-quarter to $243B.

Based on Susquehanna International Group's 13F filing for Q1 2019, filed 15 May 2019.